“Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling”, Rev Diabet Stud, pp. 62–76, Jun. 2026, doi: 10.70082/y1zx3j95.